Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2002
06/06/2002WO2001064884A3 G12l, a gene associated with the thermal response
06/06/2002WO2001053836A3 Identification, assessment, prevention, and therapy of prostate cancer
06/06/2002WO2001051652A3 Method for identifying a mark applied on a solid body
06/06/2002WO2001048209B1 Genes identified as required for proliferation of e. coli
06/06/2002WO2001044516A3 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay
06/06/2002WO2001044499A9 Modified labeled complement components for immunoassays
06/06/2002WO2001042497A9 Monitoring oligonucleotide binding processes using chemiluminescence quenching
06/06/2002WO2001031014A3 G protein-coupled receptors expressed in human brain
06/06/2002WO2000065346A9 Diagnosis of human kidney diseases
06/06/2002WO2000063421A9 A system and method for molecule selection using extended target shape
06/06/2002WO2000031531A8 Monitoring patient compliance and bioavailability of drugs by deproteinizing body fluids
06/06/2002WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents
06/06/2002WO2000022430A3 Neisseria genomic sequences and methods of their use
06/06/2002US20020069424 Protein-protein interactions in neurodegenerative disorders
06/06/2002US20020069043 System, Method, and computer program product for the visualization and interactive processing and analysis of chemical data
06/06/2002US20020069021 Automobile oil deterioration diagnosing apparatus
06/06/2002US20020068860 Comprises glucose oxidase emulsion with perfluorocarbon which is used with miniature polarographic device; gels
06/06/2002US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects
06/06/2002US20020068731 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
06/06/2002US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody.
06/06/2002US20020068707 Iga nephropathy-related genes
06/06/2002US20020068704 Compositions and methods for treatment of diabetes
06/06/2002US20020068691 Breast specific gene or "BSGs" consisting of specific nucleotide sequences and proteins expressed by these gene; vaccine for prevention of breast cancer
06/06/2002US20020068367 Linker and method for solid phase combinatorial synthesis
06/06/2002US20020068366 Proteomic analysis by parallel mass spectrometry
06/06/2002US20020068361 Methods of evaluating specific cellular functions of receptor protein tyrosine kinases in a ligand independent manner
06/06/2002US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents
06/06/2002US20020068346 Enzymatic polypeptide for use in the prevention and treatment of viral diseases
06/06/2002US20020068329 Fusion proteins for prodrug activation
06/06/2002US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics
06/06/2002US20020068319 32 human secreted proteins
06/06/2002US20020068316 Method for predicting the efficacy of anti-cancer drugs
06/06/2002US20020068315 Method of testing adequacy of cells in a specimen
06/06/2002US20020068313 Methods of diagnosing and treating crohn's disease using pseudomonas antigens
06/06/2002US20020068308 Fluorescent capture assay for kinase activity employing anti-phosphotyrosine antibodies as capture and detection agents
06/06/2002US20020068305 Detecting modulators of intergin binding activity; obtain cell that expresses preferential integrin, incubate with modulator, monitor cells for reduction in binding activity
06/06/2002US20020068303 Protein for us ein the treatment of immunological defects
06/06/2002US20020068301 Cyclic peptide libraries and methods of use thereof to identify binding motifs
06/06/2002US20020068298 Methods of identifying compounds that bind to target species under isothermal denaturing conditions
06/06/2002US20020068295 Microaarray for use in the detection of preferential particles in solution
06/06/2002US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein
06/06/2002US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer
06/06/2002US20020068278 Protein for use as antitumor agent; for use as antimetastsis agent
06/06/2002US20020068276 Methods for selecting functional polypeptides
06/06/2002US20020068274 Adjusting open reading frames of preferential nucleotide sequences; obtain plasmid, insert sequence, transform cell with plasmid, monitor gene expression and activity in lymphocytes
06/06/2002US20020068273 Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT (mitochondrial adenine nucleotide translocator)
06/06/2002US20020068271 Methods for identifying agents capable of modulating protein kinase C theta (PKC0) activity
06/06/2002US20020068270 Assessment of intracellular cysteine and glutathione concentrations
06/06/2002US20020068269 Apparatus for use in efficient evaluating signal transduction activity
06/06/2002US20020068157 Products with biofunctional coating
06/06/2002US20020068069 spsA polynucleotides and polypeptides
06/06/2002US20020068068 Pathogenic bacteria (e.g. Haemophilus, E. Coli, Salmonella) having non-reverting genetic mutations which alter activity of DNA adenine methylase (Dam); vaccines
06/06/2002US20020068063 Regulating protein activity with an ubiquitin pathway protein binding moiety coupled to a targeting moiety; used to perform target ubiquitination
06/06/2002US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
06/06/2002US20020068058 Autoantibody inhibitors
06/06/2002US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
06/06/2002US20020068048 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/06/2002US20020068036 Novel methods of diagnosis of prostate cancer and/or breast cancer, compositions, and methods of screening for prostate cancer and /or breast cancer modulators
06/06/2002US20020068019 Bio-substance using the sensor material in which a change in tone is detected on the basis of swelling or shrinking of the stimulus-responsive high polymer gel
06/06/2002US20020068018 Compact sensor using microcavity structures
06/06/2002US20020068017 Supplying an organic carbon sample and an oxidant gas to a cell transparent to plasma, establishing a low energy plasma in the cell and measuring carbon dioxide thus produced by oxidation using infra-red or conducitive techniques
06/06/2002US20020067880 Optical switch
06/06/2002US20020067800 Apparatus and method for identification of crystals by in-situ X-ray diffraction
06/06/2002US20020067603 Method and apparatus employing fluorescence for the detection of coated regions on a monofilament braid
06/06/2002US20020067476 Analytical method and apparatus for blood using near infrared spectroscopy
06/06/2002US20020067173 Apparatus and method for determining a drying time of a piece of wood
06/06/2002US20020067155 Apparatus for the detection and measurement of particulars in molten metal
06/06/2002US20020066545 Imaging the paper web with a thermal camera on a continual basis to detect defects in the web, and adjusting a treatment or manufacturing process based on the detected defects
06/06/2002US20020066442 Dynamic EGR concentration estimation method for a motor vehicle engine
06/06/2002US20020066305 Moisture detection
06/06/2002EP1144454A3 Modified peptides as therapeutic agents
06/06/2002DE10121521A1 Verschlechterungsdetektor für einen Abgassensor und Verfahren zum Detektieren einer Verschlechterung Deterioration detector for an exhaust gas sensor and method for detecting a deterioration
06/06/2002DE10061159A1 Simultaneous detection of many biomolecules, useful e.g. for diagnosis, from interaction between immobilized and test compounds, at least one being fluorescent
06/06/2002DE10060140A1 Multimerer mehrfach-antigenbindender einzelkettiger Antikörper Multimeric multiple antigen-binding single chain antibody
06/06/2002DE10059720A1 Verwendung intramolekular kovalent vernetzter Proteine als Bindepartner in Immunoassays Use intramolecular covalent cross-links proteins as binding partners in immunoassays
06/06/2002DE10058643A1 Heizeinrichtung Heater
06/06/2002DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction
06/06/2002DE10058013A1 Gasmeßfühler Gas sensor
06/06/2002DE10057841A1 Verfahren zum Nachweis von Protozoen der Gattung Naegleria A method for the detection of protozoa of the genus Naegleria
06/06/2002DE10056704A1 Determining analytes by specific interaction, useful e.g. for blood enzymes and metabolites, based on change in a signal in the middle infra-red region
06/06/2002DE10054635A1 Clinically validating target from disseminated cancer cells by determining whether status of target determined in cancer cells of individuals correlates with cancer-related information about clinical status of individuals
06/06/2002CA2791831A1 Rna interference mediating small rna molecules
06/06/2002CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
06/06/2002CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
06/06/2002CA2430745A1 Master bone formation transcription factor: compositions and methods of use
06/06/2002CA2430559A1 Method of making a protein polymer and uses of the polymer
06/06/2002CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
06/06/2002CA2430503A1 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
06/06/2002CA2430485A1 Cytonkine receptor zcytor19
06/06/2002CA2430476A1 Analyzing molecular diversity by total pharmacophore diversity
06/06/2002CA2430473A1 Diagnosis and treatment of disease
06/06/2002CA2430430A1 Method and apparatus using a surface-selective nonlinear optical technique for detection of probe-target interactions
06/06/2002CA2430401A1 Uses of mammalian genes and related reagents
06/06/2002CA2430336A1 Membrane molecule indicator compositions and methods
06/06/2002CA2430331A1 Human cervical cancer 2 protooncogene and protein encoded therein
06/06/2002CA2430301A1 Static micro-array of biological or chemical probes immobilised on a support by magnetic attraction
06/06/2002CA2430269A1 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism
06/06/2002CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002CA2430174A1 Novel method for screening bacterial transcription modulators
06/06/2002CA2430138A1 Compositions and methods for extracting a nucleic acid